START STRONG with EYLEA®

Rapid, early vision gains are observed in CRVO patients treated within 2 months of diagnosis1

CRVO COPERNICUS Results: VA improvement at Week 24

CRVO, central retinal vein occlusion; VA, visual acuity.

Reference

  1. Boyer D, Heier J, Brown DM, et al. Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. Ophthalmology. 2012;119(5):1024-1032.